Search Form
First, enter a politician or zip code
Now, choose a category

Orrin Hatch's Public Statements on Issue: Drugs

Office: U.S. Senate (UT) - Sr, Republican President Pro Tempore
Date Title
Dec. 12, 2017 Tweet - "Today the Senate Judiciary Committee is holding a hearing on "the Ensuring Patient Access and Effective Drug Enforcement Act," legislation that was the target of a recent terribly flawed Washington Post/60 Minutes report. …"
Dec. 12, 2017 Tweet - "Disappointed by WaPo's report on today's hearing. The report repeats claims from previous Post articles that DEA's own data and that testimony from DEA's own witness directly contradict. One might think the reporters didn't actually watch the hearing."
Dec. 12, 2017 Hearing of the Senate Judiciary Committee - Opening Statement of Sen. Hatch, Hearing on Oversight of the Ensuring Patient Access and Effective Drug Enforcement Act
Dec. 8, 2017 Tweet - "Timely reminder: in October Hatch pressed Attorney General Sessions on the importance of medical marijuana research, and ensuring DOJ isn't hindering those efforts."
Nov. 8, 2017 Tweet - "Hatch has been working for months to being the DEA 360 program to Utah. Will be a great help in our efforts to fight the opioid epidemic. #utpol"
Nov. 8, 2017 Hatch Statement on Utah Unveiling of DEA 360 Program
Nov. 8, 2017 Letter to Jeff Sessions, Attorney General - Provide Guidance on Boosting Support for Forensic Labs In Efforts to Combat Opioid Epidemic
Oct. 26, 2017 Wyden Statement on Opioid Public Health Emergency Declaration
Oct. 12, 2017 Huffington Post - It's High Time We Research Medical Marijuana
Sept. 13, 2017 Hatch Introduces Medical Marijuana Research Bill
Sept. 13, 2017 Hatch to Speak on Medical Marijuana Research, Possible Benefits
Sept. 13, 2017 Statements on Introduced Bills and Joint Resolutions
Aug. 8, 2017 Hatch Commends President's Focus on Opioid Epidemic
Sept. 20, 2016 Letter to the Honorable Daniel Levinson, Inspector General of the Dept. of Health and Human Services - Call for Review of Rebate Practices for Mylan's EpiPen
Sept. 16, 2016 Letter to the Honorable John Kerry, Secretary of the Dept. of State - Address Trafficking of Synthetic Drugs and Illicit Goods Through Mail Service
Sept. 5, 2016 Washington Post - A Better Way to Help Vulnerable Children and Families
July 14, 2016 Finance Committee Continues Momentum in Second Session of 114th Congress
July 12, 2016 Energy Policy Modernization Act of 2015
July 7, 2016 House-Senate Opioid Conference Report Finalized
July 6, 2016 Hearing of the Comprehensive Addiction and Recovery Act Conference Committee - Opening Statement of Rep. Murray
July 5, 2016 Letter to the Honorable Fred Upton, Chairman of the Committee on Energy and Commerce - Refusal to Sign Opioid Conference Report Without Funding to Combat Drug Addiction Epidemic
June 20, 2016 Hatch Introduces Bipartisan Legislation to Facilitate Research on the Medical Value of Marijuana
June 17, 2016 Gardner, Hatch, Johnson Introduce Amendment to Provide Life-Saving Treatment to Epilepsy Patients
June 16, 2016 Finance Senators Introduce Family First Prevention Services Act
June 16, 2016 Utah Leaders Praise Hatch Legislation that Keeps Families Together
June 10, 2016 Bipartisan House, Senate Leaders Announce Proposed Child Welfare Legislation
June 2, 2016 Letter to Mr. Gene L. Dodaro, Comptroller General of the United States, U.S. Government Accountability Office - Review Sober Living Home Federal and State Oversight
June 2, 2016 Senators Hatch and Markey Call on HHS to Follow Senate Lead in Increasing Access to Opioid Addiction Treatment
June 1, 2016 Letter to The Honorable Sylvia M. Burwell, Secretary of Health and Human Services - Urging DHHS to Increase Access to Opioid Addiction Treatment
April 13, 2016 Hatch Bill Targeting Prescription Drug Abuse Heads to President's Desk for Signature
April 12, 2016 House Passes Hatch-Whitehouse Bill to Prevent Illicit Transfer of Prescription Drugs
April 6, 2016 Senate HELP Committee Holds Mark-up for PATH Act to Create Streamlined Antibiotic Approval Pathway
March 18, 2016 Hatch and Whitehouse's Ensuring Patient Access and Effective Drug Enforcement Act Passes Senate
March 15, 2016 Cochran Cosponsors Pain Prevention, Treatment Research Bill
March 10, 2016 Hatch Hails Passage of Bill to Curtail Heroin and Opioid Abuse
Feb. 23, 2016 Hearing of the Senate Committee on Finance - Opening Statement of Sen. Orrin Hatch - Hearing to Examine the Opioid Epidemic
Feb. 23, 2016 Hatch Statement at Finance Committee Hearing Examining the Opioid Epidemic
Feb. 23, 2016 Hatch Statement on the Confirmation of Robert Califf as FDA Commissioner
Feb. 23, 2016 Ensuring Patient Access and Effective Drug Enforcement Act
Feb. 11, 2016 Hatch-Whitehouse Bill to Prevent Prescription Drug Abuse Advances in the Senate
Jan. 19, 2016 Hatch Applauds Supreme Court's Decision to Review Obama Immigration Orders
Oct. 28, 2015 Letter to Howard Shelanski, Administrator, Office of Information and Regulatory Affairs - Halt Harmful Opioid Rule
Oct. 27, 2015 Letter to the Honorable Edith Ramirez, Chairwoman of the Federal Trade Commission - Urge for FTC to Investigate Antitrust Violations Connected to IV Solution Shortages
Aug. 7, 2015 Letter to the Hon. Sylvia Burwell, Secretary, U.S. Department of Health and Human Services - Increase Access to Treatment for Prescription Pain Addiction
Aug. 4, 2015 Letter to Members of the Senate - Join Effort to Provide Life-Saving Treatment to Epilepsy Patients
May 13, 2015 Senate Coalition To Introduce Bill Providing Access To Epilepsy Treatment
Feb. 12, 2015 Senators Hatch, Whitehouse Introduce Legislation to Streamline Drug Development Process and Protect Patient Access to Medications
Feb. 3, 2015 Hatch Introduces Bill to Fight Illegal Marijuana Growth
Dec. 12, 2014 Senate Approves Bipartisan Bill to Protect Consumers from Steroids
Sept. 24, 2014 Hatch on the 30th Anniversary of Hatch-Waxman Law
Skip to top

Help us stay free for all your Fellow Americans

Just $5 from everyone reading this would do it.

Back to top